Marloes de Kovel: FVIII Exposure With Severe Haemophilia A on Emicizumab Prophylaxis
Marloes de Kovel, Epidemiologist and Research Coordinator at PedNet Haemophilia Research Foundation, shared a Journal of Thrombosis and Haemostasis‘s post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Delighted to share our brief report on FVIII exposure, bleeding outcomes, and inhibitor development in PUPs and MTPs with severe haemophilia A on emicizumab prophylaxis.”
Journal of Thrombosis and Haemostasis shared a post on LinkedIn:
“FVIII exposure, bleeding outcomes, and inhibitor development in 80 PUPs and MTPs with severe hemophilia A on emicizumab prophylaxis: real-world data from the PedNet Registry
Real-world data on emicizumab in infants with severe hemophilia A remain thin beyond HAVEN 7.
Across 80 previously or minimally treated infants in the PedNet Registry, first FVIII exposure was delayed and bleeding control was good, with a mean annualized bleeding rate of 0.6.
Five developed inhibitors, and preliminary analysis suggested no drop in inhibitor development. No thrombosis occurred.”
Title: Factor VIII exposure, bleeding outcomes, and inhibitor development in 80 previously untreated patients and minimally treated patients with severe hemophilia A on emicizumab prophylaxis: real-world data from the PedNet Registry
Authors: Marloes de Kovel, Gili Kenet, Jayashree Motwani, Nadine G. Andersson, Jan Blatný, Giancarlo Castaman, Manuel Carcao, Carmen Escuriola Ettingshausen, Christoph Königs, Christoph Male, Beatrice Nolan, Martin Olivieri, Caroline Oudot, Helen Pergantou, Susanna Ranta, Ester Zapotocka, Kathelijn Fischer
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC
-
Oct 10, 2026, 00:34Raphaëlle Dodart: Discussing the Mechanisms of Menstrual Hemostasis
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia